New York 2025-2026 Regular Session

New York Senate Bill S00992

Introduced
1/8/25  
Refer
1/8/25  

Caption

Relates to care and protection of children; adds to the definition of children at risk infants who test positive for a controlled substance not prescribed by a physician, in their bloodstream or urine, are born dependent on such drugs or who demonstrate drug withdrawal symptoms, or who have been diagnosed with a condition attributable to in utero exposure to illegal drugs.

Companion Bills

No companion bills found.

Previously Filed As

NY S07460

Directs the commissioner of health to establish at least 4 maternal-infant care centers in areas of need for infants suffering from drug withdrawal as a result of in utero exposure.

NY SB6

Exposure Of Children To Drugs

NY S03883

Relates to dispensing certain controlled substances for use by a person with a substance use disorder during certain emergency medical treatment, or to relieve acute withdrawal symptoms.

NY A02253

Relates to dispensing certain controlled substances for use by a person with a substance use disorder during certain emergency medical treatment, or to relieve acute withdrawal symptoms.

NY HB473

Criminalizing multiple forms of exposing children to controlled substances and allowing law enforcement to take a child into protective custody for screening and testing in an instance of suspected or actual criminal exposure to controlled substances.

NY A08961

Relates to the definition of drug-related paraphernalia; clarifies that drug-related paraphernalia shall not impact substances that are not considered controlled substances.

NY S08520

Relates to the definition of drug-related paraphernalia; clarifies that drug-related paraphernalia shall not impact substances that are not considered controlled substances.

NY A08217

Alters the definition of "drug" to include any substance or combination of substances that impair, to any extent, physical or mental abilities.

NY A11256

Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.

NY A08723

Provides a legacy credit to the children and siblings of veterans who were killed in the line of duty including veterans who were disabled as a result of their service, exposed to toxic substances, or presumptive conditions determined by the department of veterans affairs.

Similar Bills

No similar bills found.